DK1011646T3 - Farmaceutiske præparater og indretninger til administration heraf - Google Patents

Farmaceutiske præparater og indretninger til administration heraf

Info

Publication number: DK1011646T3
Authority: DK; Denmark
Prior art keywords: hfc; container; carrier; administration; devices
Prior art date: 1996-12-04

Application number

DK97947786T

Other languages

English (en)

Inventor

Paul Mccarthy

Michael Goodman

Ake Lindahl

Original Assignee

Link Products Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-12-04

Filing date

1997-12-04

Publication date

2005-09-19

1996-12-04 Priority claimed from GBGB9625171.5A external-priority patent/GB9625171D0/en

1996-12-20 Priority claimed from GBGB9626449.4A external-priority patent/GB9626449D0/en

1997-12-04 Application filed by Link Products Ltd filed Critical Link Products Ltd

2005-09-19 Application granted granted Critical

2005-09-19 Publication of DK1011646T3 publication Critical patent/DK1011646T3/da

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 3
YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 abstract 2
LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 abstract 1
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 abstract 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000000443 aerosol Substances 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
235000014113 dietary fatty acids Nutrition 0.000 abstract 1
229960001760 dimethyl sulfoxide Drugs 0.000 abstract 1
229930195729 fatty acid Natural products 0.000 abstract 1
239000000194 fatty acid Substances 0.000 abstract 1
229920001515 polyalkylene glycol Polymers 0.000 abstract 1
229920000728 polyester Polymers 0.000 abstract 1
229920005862 polyol Polymers 0.000 abstract 1
150000003077 polyols Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nozzles (AREA)

DK97947786T 1996-12-04 1997-12-04 Farmaceutiske præparater og indretninger til administration heraf DK1011646T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9625171.5A GB9625171D0 (en)	1996-12-04	1996-12-04	Pharmaceutical compositions and devices for their administration
GBGB9626449.4A GB9626449D0 (en)	1996-12-20	1996-12-20	Pharmaceutical compositions and device for their administration
PCT/GB1997/003360 WO1998024420A1 (en)	1996-12-04	1997-12-04	Pharmaceutical compositions and devices for their administration

Publications (1)

Publication Number	Publication Date
DK1011646T3 true DK1011646T3 (da)	2005-09-19

Family

ID=26310542

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97947786T DK1011646T3 (da)	1996-12-04	1997-12-04	Farmaceutiske præparater og indretninger til administration heraf

Country Status (13)

Country	Link
EP (1)	EP1011646B1 (da)
JP (1)	JP2001505171A (da)
KR (1)	KR20000069275A (da)
AT (1)	ATE301991T1 (da)
AU (1)	AU726510B2 (da)
CA (1)	CA2273835A1 (da)
DE (1)	DE69734017T2 (da)
DK (1)	DK1011646T3 (da)
ES (1)	ES2244008T3 (da)
IE (1)	IES80485B2 (da)
NO (1)	NO992677L (da)
NZ (1)	NZ336049A (da)
WO (1)	WO1998024420A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9616237D0 (en)	1996-08-01	1996-09-11	Norton Healthcare Ltd	Aerosol formulations
GB2326334A (en) †	1997-06-13	1998-12-23	Chiesi Farma Spa	Pharmaceutical aerosol compositions
US20010031244A1 (en)	1997-06-13	2001-10-18	Chiesi Farmaceutici S.P.A.	Pharmaceutical aerosol composition
US6451285B2 (en)	1998-06-19	2002-09-17	Baker Norton Pharmaceuticals, Inc.	Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6509005B1 (en) *	1998-10-27	2003-01-21	Virginia Commonwealth University	Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
DZ2947A1 (fr) *	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
US6290930B1 (en) *	1998-12-18	2001-09-18	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6315985B1 (en)	1999-06-18	2001-11-13	3M Innovative Properties Company	C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it)	1999-07-23	2002-09-09	Chiesi Farma Spa	Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
CA2317999C (en) *	1999-09-11	2004-11-09	Glaxo Group Limited	Pharmaceutical formulation of fluticasone propionate
GB2388843B (en) *	1999-09-11	2004-03-03	Glaxo Group Ltd	A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate
EP1248597B1 (en) *	1999-12-24	2005-03-30	Glaxo Group Limited	Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it)	2000-02-22	2003-07-15	Chiesi Farma Spa	Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
ES2280343T3 (es) *	2000-03-09	2007-09-16	Gw Pharma Limited	Composiciones farmaceuticas que contienen cannabis.
JP5392880B2 (ja)	2000-05-22	2014-01-22	キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ	加圧式定量吸入器のための安定な製薬学的溶液製剤
WO2001097780A2 (en) *	2000-06-22	2001-12-27	Pharmasol Ltd	Pharmaceutical compositions comprising an opioid analgesic
GB0015361D0 (en) *	2000-06-22	2000-08-16	Pharmasol Ltd	Improvements in pharmaceutical compositions
AU2002238748A1 (en) *	2001-03-12	2002-09-24	Glaxo Group Limited	Pharmaceutical aerosol formulation
DE60103527T2 (de)	2001-07-02	2005-06-16	Chiesi Farmaceutici S.P.A.	Optimierte Tobramycin-Formulierung zur Aerosolbildung
AU2002361850A1 (en) *	2001-12-21	2003-07-30	3M Innovative Properties Company	Medicinal aerosol formulations comprising ion pair complexes
EP1321159A1 (en) *	2001-12-21	2003-06-25	CHIESI FARMACEUTICI S.p.A.	Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
US7255102B2 (en)	2002-02-01	2007-08-14	Generex Pharmaceuticals Inc.	Metered dose spray device for use with macromolecular pharmaceutical agents such as insulin
EP1340492A1 (en) *	2002-03-01	2003-09-03	CHIESI FARMACEUTICI S.p.A.	Aerosol formulations for pulmonary administration of medicaments having systemic effects
US7767698B2 (en)	2002-06-03	2010-08-03	Mcneil Ab	Formulation and use thereof
GB0311701D0 (en) *	2003-05-21	2003-06-25	Karib Kemi Pharm Liited	Improved metered dose inhaler product
AR041873A1 (es) *	2003-10-30	2005-06-01	Pablo Cassara Srl Lab	Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
EP1595531A1 (en)	2004-05-13	2005-11-16	CHIESI FARMACEUTICI S.p.A.	Stable pharmaceutical solution formulations for pressurized metered dose inhalers
KR100776770B1 (ko) *	2006-07-18	2007-11-29	(주)비엔에프	고압분사 에어로졸 밸브
US8578942B2 (en)	2010-05-25	2013-11-12	British American Tobacco (Investments) Limited	Aerosol generator
JP5409594B2 (ja) *	2010-12-22	2014-02-05	キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ	加圧式定量吸入器のための安定な製薬学的溶液製剤
RU2541312C2 (ru) *	2011-08-31	2015-02-10	Александр Васильевич Иващенко	Фармацевтическая композиция, способ ее получения и устройство для ее применения
JP6166453B2 (ja) *	2015-12-28	2017-07-19	花王株式会社	エアゾール化粧料
GB201912686D0 (en) *	2019-09-04	2019-10-16	Reown Pharma Inc	Pharmaceutical composition
KR102726961B1 (ko) *	2022-12-13	2024-11-06	주식회사 대웅제약	비강용 투약장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6907687A (en) *	1986-02-18	1987-08-20	Rorer Pharmaceutical Corporation	Composition for treatment of asthmatic conditions using phenoxymethyl quinolines
AU658854B2 (en) *	1990-10-18	1995-05-04	Minnesota Mining And Manufacturing Company	Aerosol formulation comprising beclomethasone 17,21 dipropionate
DK1277467T3 (da) *	1991-06-10	2007-01-15	Schering Corp	Formuleringer af ikke-chlorfluorcarbonaerosoler
FR2705570B1 (fr) *	1993-05-25	1995-07-13	Adir	Nouvelle formulation d'aérosol médicamentaux à base de fusafungine, son procédé de préparation et les compositions pharmaceutiques qui la contiennent.
CA2218179A1 (en) *	1995-04-14	1996-10-17	Glaxo Wellcome Inc.	Metered dose inhaler for beclomethasone dipropionate
GB9517998D0 (en) *	1995-09-04	1995-11-08	Bioglan Lab Ltd	Compositions and device for their administration

1997
- 1997-12-04 JP JP52536298A patent/JP2001505171A/ja active Pending
- 1997-12-04 IE IE970858 patent/IES80485B2/en not_active IP Right Cessation
- 1997-12-04 AU AU54028/98A patent/AU726510B2/en not_active Expired
- 1997-12-04 WO PCT/GB1997/003360 patent/WO1998024420A1/en not_active Ceased
- 1997-12-04 EP EP97947786A patent/EP1011646B1/en not_active Expired - Lifetime
- 1997-12-04 DK DK97947786T patent/DK1011646T3/da active
- 1997-12-04 AT AT97947786T patent/ATE301991T1/de not_active IP Right Cessation
- 1997-12-04 KR KR1019997004899A patent/KR20000069275A/ko not_active Withdrawn
- 1997-12-04 DE DE69734017T patent/DE69734017T2/de not_active Expired - Lifetime
- 1997-12-04 NZ NZ336049A patent/NZ336049A/xx unknown
- 1997-12-04 ES ES97947786T patent/ES2244008T3/es not_active Expired - Lifetime
- 1997-12-04 CA CA002273835A patent/CA2273835A1/en not_active Abandoned
1999
- 1999-06-02 NO NO992677A patent/NO992677L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ATE301991T1 (de)	2005-09-15
AU726510B2 (en)	2000-11-09
DE69734017D1 (de)	2005-09-22
CA2273835A1 (en)	1998-06-11
NZ336049A (en)	2000-09-29
WO1998024420A1 (en)	1998-06-11
DE69734017T2 (de)	2006-06-14
NO992677L (no)	1999-07-15
JP2001505171A (ja)	2001-04-17
IES970858A2 (en)	1998-08-12
NO992677D0 (no)	1999-06-02
IES80485B2 (en)	1998-08-12
EP1011646A1 (en)	2000-06-28
EP1011646B1 (en)	2005-08-17
KR20000069275A (ko)	2000-11-25
AU5402898A (en)	1998-06-29
ES2244008T3 (es)	2005-12-01

Publication	Publication Date	Title
NO992677D0 (no)	1999-06-02	Farmas°ytiske preparater og innretninger for deres administrasjon
US6413496B1 (en)	2002-07-02	Pharmaceutical compositions and devices for their administration
CA2477879A1 (en)	2003-09-12	Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
NZ509418A (en)	2003-06-30	Pharmaceutical formulations for aerosols with two or more active substances
KR910007512A (ko)	1991-05-30	국소 약제 가압에어로졸 조성물 및 그를 함유한 에어로졸 콘테이너의 제조방법
CA2353847A1 (en)	2000-06-29	Pulmonary drug delivery
NZ330369A (en)	2000-04-28	aqueous medicaments containing 9-hydroxy-risperidone fatty acid ester
DK0553298T3 (da)	1995-04-18	Aerosolformulering omfattende beclomethason-17,21-dipropionat
IL151603A0 (en)	2003-04-10	A pharmaceutical composition containing cannabis and devices for delivering the same
AU601176B2 (en)	1990-09-06	Benzodiazepine aerosols
EP1277467A3 (en)	2003-04-16	Non-chlorofluorocarbon aerosol formulations
ATE91894T1 (de)	1993-08-15	Arzneizubereitungen zur transdermalen verabreichung von wirkstoffen.
CA2151383A1 (en)	1994-06-23	Stabilized medicinal aerosol solution formulation
PT731688E (pt)	2003-07-31	Formulacoes de farmacos em aerossol para utilizacao com propulsores sem cfc
IL129300A (en)	2003-07-06	Liquid pharmaceutical composition comprising an hiv protease inhibitor or a combination of hiv protease inhibitors in a pharmaceutically acceptable organic solvent
NO980858D0 (no)	1998-02-27	Farmasöytiske preparater og anordninger for administrering derav
HK1041446A1 (en)	2002-07-12	Sublingual delivery of cannabis
PE20020055A1 (es)	2002-02-12	Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
TH65855A (th)	2004-12-27	สูตรผสมชนิดละอองลอยของยาสำหรับการให้ทางปอดเพื่อให้เกิดผลทั่วร่างกาย
MX9604004A (es)	1997-12-31	Formualciones de farmaco en aerosol que contienen vitamina e.